原著 |
|
|
|
|
国产载药微球经动脉化疗栓塞治疗不可切除原发性肝癌的临床研究 |
陈刚1,2( ),张鼎2,应亚草2,王志峰2,陶伟2,朱皓2,张景峰1,*( ),彭志毅1,*( ) |
(1) 浙江大学医学院附属第一医院放射科, 浙江 杭州 310003 (2) 宁波市中医院放射科, 浙江 宁波 315010 |
|
Clinical investigation on transarterial chemoembolization with indigenous drug-eluting beads in treatment of unresectable hepatocellular carcinoma |
CHEN Gang1,2( ),ZHANG Ding2,YING Yacao2,WANG Zhifeng2,TAO Wei2,ZHU Hao2,ZHANG Jingfeng1,*( ),PENG Zhiyi1,*( ) |
(1) Department of Radiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (2) Department of Radiology, Traditional Chinese Medicine Hospital of Ningbo, Ningbo 315010, China |
引用本文:
陈刚,张鼎,应亚草,王志峰,陶伟,朱皓,张景峰,彭志毅. 国产载药微球经动脉化疗栓塞治疗不可切除原发性肝癌的临床研究[J]. 浙江大学学报(医学版), 2017, 46(1): 44-51.
CHEN Gang,ZHANG Ding,YING Yacao,WANG Zhifeng,TAO Wei,ZHU Hao,ZHANG Jingfeng,PENG Zhiyi. Clinical investigation on transarterial chemoembolization with indigenous drug-eluting beads in treatment of unresectable hepatocellular carcinoma. J Zhejiang Univ (Med Sci), 2017, 46(1): 44-51.
链接本文:
http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2017.02.07
或
http://www.zjujournals.com/med/CN/Y2017/V46/I1/44
|
1 |
PARKIN D M, BRAY F, FERLAY J et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55(2): 74-108 doi: 10.3322/canjclin.55.2.74
doi: 10.3322/canjclin.55.2.74
|
2 |
CUCCHETTI A, TREVISANI F, CESCON M et al. Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. J Hepatol. 2012, 56(5): 1089-1096 doi: 10.1016/j.jhep.2011.11.022
doi: 10.1016/j.jhep.2011.11.022
pmid: 22245900
|
3 |
BRUIX J, SHERMAN M . Management of hepatocellular carcinoma. Hepatology. 2005, 42(5): 1208-1236 doi: 10.1002/hep.v42:5
|
4 |
European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer . EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma. J Hepatol. 2012, 56(4): 908-943 doi: 10.1016/j.jhep.2011.12.001
doi: 10.1016/j.jhep.2011.12.001
pmid: 22424438
|
5 |
MARELLI L, STIGLIANO R, TRIANTOS C et al. Transarterial therapy for hepatocellular carcinoma:which technique is more effective? a systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007, 30(1): 6-25 doi: 10.1007/s00270-006-0062-3
|
6 |
VARELA M, REAL M I, BURREL M et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads:efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007, 46(3): 474-481 doi: 10.1016/j.jhep.2006.10.020
doi: 10.1016/j.jhep.2006.10.020
|
7 |
POON R T, TSO W K, PANG R W et al. A phase Ⅰ/Ⅱ trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol. 2007, 5(9): 1100-1108 doi: 10.1016/j.cgh.2007.04.021
doi: 10.1016/j.cgh.2007.04.021
pmid: 17627902
|
8 |
LENCIONI R, PETRUZZI P, CROCETTI L . Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol. 2013, 30(1): 3-11 doi: 10.1055/s-00000068
|
9 |
DHANASEKARAN R, KOOBY D A, STALEY C A et al. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol. 2010, 101(6): 476-480
|
10 |
VOGL T J, LAMMER J, LENCIONI R et al. Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads:results from the PRECISION V randomized trial. AJR Am J Roentgenol. 2011, 197(4): W562-W570 doi: 10.2214/AJR.10.4379
doi: 10.2214/AJR.10.4379
pmid: 21940527
|
11 |
FORNER A, REIG M E, DE LOPE C R et al. Current strategy for staging and treatment:the BCLC update and future prospects. Semin Liver Dis. 2010, 30(1): 61-74 doi: 10.1055/s-0030-1247133
doi: 10.1055/s-0030-1247133
pmid: 20175034
|
12 |
LEWIS A L, TAYLOR R R, HALL B et al. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol. 2006, 17(8): 1335-1343 doi: 10.1097/01.RVI.0000228416.21560.7F
doi: 10.1097/01.RVI.0000228416.21560.7F
pmid: 16923981
|
13 |
HONG K, KHWAJA A, LIAPI E et al. New intra-arterial drug delivery system for the treatment of liver cancer:preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006, 12(8): 2563-2567 doi: 10.1158/1078-0432.CCR-05-2225
doi: 10.1158/1078-0432.CCR-05-2225
pmid: 16638866
|
14 |
Varela M, Real M I, Burrel M et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads:efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007, 46(3): 474-481 doi: 10.1016/j.jhep.2006.10.020
doi: 10.1016/j.jhep.2006.10.020
|
15 |
MALAGARI K, ALEXOPOULOU E, CHATZIMICHAIL K et al. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments:midterm results of doxorubicin-loaded DC bead. Abdom Imaging. 2008, 33(5): 512-519 doi: 10.1007/s00261-007-9334-x
doi: 10.1007/s00261-007-9334-x
pmid: 17938995
|
16 |
SONG M J, PARK C H, KIM J D et al. Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma:a case-control study of Asian patients. Eur J Gastroenterol Hepatol. 2011, 23(6): 521-527 doi: 10.1097/MEG.0b013e328346d505
doi: 10.1097/MEG.0b013e328346d505
pmid: 21537127
|
17 |
LAMMER J, MALAGARI K, VOGL T et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma:results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010, 33(1): 41-52 doi: 10.1007/s00270-009-9711-7
doi: 10.1007/s00270-009-9711-7
pmid: 2816794
|
18 |
GOLFIERI R, GIAMPALMA E, RENZULLI M et al. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. Br J Cancer. 2014, 111(2): 255-264 doi: 10.1038/bjc.2014.199
doi: 10.1038/bjc.2014.199
pmid: 24937669
|
19 |
FACCIORUSSO A, MARIANI L, SPOSITO C et al. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Gastroenterol Hepatol. 2016, 31(3): 645-653 doi: 10.1111/jgh.2016.31.issue-3
doi: 10.1016/j.dld.2016.02.005
pmid: 26965785
|
20 |
BAUR J, RITTER C O, GERMER C T et al. Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma. Hepat Med. 2016, 8: 69-74
|
21 |
SCARTOZZI M, BARONI G S, FALOPPI L et al. Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma:efficacy and safety results from a large mono-institutional analysis. J Exp Clin Cancer Res. 2010, 29: 164 doi: 10.1186/1756-9966-29-164
|
22 |
VOGL T J, LAMMER J, LENCIONI R et al. Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads:results from the PRECISION V randomized trial. AJR Am J Roentgenol. 2011, 197(4): W562-W570 doi: 10.2214/AJR.10.4379
doi: 10.2214/AJR.10.4379
pmid: 21940527
|
23 |
GOLFIERI R, GIAMPALMA E, RENZULLI M et al. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. Br J Cancer. 2014, 111(2): 255-264 doi: 10.1038/bjc.2014.199
doi: 10.1038/bjc.2014.199
pmid: 24937669
|
24 |
WALDRAM R, WILLIAMS R, CALNE R Y . Bile composition and bile cast formation after transplantation of the liver in man. Transplantation. 1975, 19(5): 382-387 doi: 10.1097/00007890-197505000-00004
doi: 10.1097/00007890-197505000-00004
pmid: 168674
|
25 |
BRANDSAETER B, SCHRUMPF E, CLAUSEN O P et al. Recurrent sclerosing cholangitis or ischemic bile duct lesions-a diagnostic challenge?. Liver Transpl. 2004, 10(8): 1073-1074 doi: 10.1002/lt.20192
doi: 10.1002/lt.20192
|
26 |
PFAU P R, KOCHMAN M L, LEWIS J D et al. Endoscopic management of postoperative biliary complications in orthotopic liver transplantation. Gastrointest Endosc. 2000, 52(1): 55-63 doi: 10.1067/mge.2000.106687
doi: 10.1067/mge.2000.106687
pmid: 10882963
|
27 |
CLERMONTS S H, VAN DAM R M . Obstructive putty-like cast of the biliary tree. Hepatobiliary Surg Nutr. 2014, 3(1): 47-49
|
28 |
BENNINGER J, GROBHOLZ R, OEZTUERK Y et al. Sclerosing cholangitis following severe trauma:description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms. World J Gastroenterol. 2005, 11(27): 4199-4205 doi: 10.3748/wjg.v11.i27.4199
doi: 10.1055/s-2005-858505
pmid: 16015689
|
29 |
GELBMANN C M, RUMMELE P, WIMMER M et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol. 2007, 102(6): 1221-1229 doi: 10.1111/ajg.2007.102.issue-6
doi: 10.1111/j.1572-0241.2007.01118.x
pmid: 17531010
|
30 |
MONIER A, GUIU B, DURAN R et al. Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma:comparison between drug-eluting beads and lipiodol emulsion. Eur Radiol. 2017, 27(4): 1431-1439 doi: 10.1007/s00330-016-4488-y
doi: 10.1007/s00330-016-4488-y
pmid: 27436016
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|